JPMorgan PE Arm Bids $1.1B For Medical Transcription Co.

Law360, New York (July 03, 2012, 4:16 PM ET) -- In the wake of last week's landmark U.S. Supreme Court health care ruling, JPMorgan Chase & Co.'s private investment arm is going after medical transcription technology outfit M*Modal Inc. in a deal valued at $1.1 billion, the parties announced Monday.

JPMorgan's One Equity partners will pay $14 per share in cash for the Tennessee-based M*Modal, which specializes in speech-recognition technology that has applications in small private practices, clinics and large hospital systems, according to a joint statement M*Modal issued Monday.

The offer represents an 8.3 percent...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required